Cargando…
Cell-Based Therapies for Trabecular Meshwork Regeneration to Treat Glaucoma
Glaucoma is clinically characterized by elevated intraocular pressure (IOP) that leads to retinal ganglion cell (RGC) and optic nerve damage, and eventually blindness if left untreated. Even in normal pressure glaucoma patients, a reduction of IOP is currently the only effective way to prevent blind...
Autores principales: | Mallick, Shayshadri, Sharma, Malini, Kumar, Ajay, Du, Yiqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465897/ https://www.ncbi.nlm.nih.gov/pubmed/34572471 http://dx.doi.org/10.3390/biom11091258 |
Ejemplares similares
-
Trabecular meshwork cells are a valuable resource for cellular therapy of glaucoma
por: Sun, Hong, et al.
Publicado: (2019) -
Endoplasmic Reticulum Stress Response of Trabecular Meshwork Stem Cells and Trabecular Meshwork Cells and Protective Effects of Activated PERK Pathway
por: Wang, Yiwen, et al.
Publicado: (2019) -
Technological advances in ocular trabecular meshwork in vitro models for glaucoma research
por: Bikuna‐Izagirre, Maria, et al.
Publicado: (2022) -
Human Trabecular Meshwork Progenitors
por: Zhu, Qin, et al.
Publicado: (2019) -
Histological Findings in the Trabecular Meshwork of a Patient with Atopic Glaucoma
por: Kase, Satoru, et al.
Publicado: (2017)